KBC Group NV Has $246,000 Stock Position in Inspire Medical Systems, Inc. (NYSE:INSP)

KBC Group NV boosted its position in shares of Inspire Medical Systems, Inc. (NYSE:INSP) by 52.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,325 shares of the company’s stock after purchasing an additional 455 shares during the period. KBC Group NV’s holdings in Inspire Medical Systems were worth $246,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the business. Wasatch Advisors LP lifted its position in Inspire Medical Systems by 1.6% during the third quarter. Wasatch Advisors LP now owns 1,323,470 shares of the company’s stock worth $279,318,000 after acquiring an additional 20,481 shares during the last quarter. State Street Corp boosted its stake in Inspire Medical Systems by 78.0% in the third quarter. State Street Corp now owns 1,049,784 shares of the company’s stock valued at $221,557,000 after buying an additional 459,990 shares in the last quarter. Janus Henderson Group PLC grew its holdings in shares of Inspire Medical Systems by 5.8% during the 3rd quarter. Janus Henderson Group PLC now owns 502,609 shares of the company’s stock valued at $106,075,000 after purchasing an additional 27,374 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Inspire Medical Systems by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 483,654 shares of the company’s stock valued at $102,102,000 after acquiring an additional 3,128 shares during the last quarter. Finally, Point72 Asset Management L.P. boosted its stake in shares of Inspire Medical Systems by 954.4% during the third quarter. Point72 Asset Management L.P. now owns 319,364 shares of the company’s stock valued at $67,402,000 after purchasing an additional 289,075 shares in the last quarter. 94.91% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on INSP shares. KeyCorp restated an “overweight” rating and issued a $234.00 target price (down previously from $236.00) on shares of Inspire Medical Systems in a report on Friday, January 24th. Stifel Nicolaus decreased their target price on shares of Inspire Medical Systems from $200.00 to $190.00 and set a “hold” rating for the company in a research report on Tuesday, January 21st. Wells Fargo & Company raised their price objective on Inspire Medical Systems from $187.00 to $198.00 and gave the company an “equal weight” rating in a research note on Tuesday, November 5th. Bank of America raised Inspire Medical Systems from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $220.00 to $255.00 in a research report on Wednesday, November 20th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $260.00 price objective on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $231.45.

Inspire Medical Systems Stock Down 0.7 %

Shares of NYSE INSP opened at $192.10 on Tuesday. Inspire Medical Systems, Inc. has a 52-week low of $123.00 and a 52-week high of $257.40. The firm has a market cap of $5.76 billion, a price-to-earnings ratio of 179.54 and a beta of 1.32. The company’s 50-day simple moving average is $190.21 and its 200-day simple moving average is $188.97.

Inspire Medical Systems (NYSE:INSP) last announced its earnings results on Monday, November 4th. The company reported $0.60 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.54. The company had revenue of $203.20 million during the quarter, compared to analyst estimates of $197.59 million. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%. Inspire Medical Systems’s revenue was up 32.6% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.29) earnings per share. Equities research analysts anticipate that Inspire Medical Systems, Inc. will post 1.35 EPS for the current fiscal year.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.